Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 81.91% of CRBP shares are held by financial institutions. CARMICHAEL HILL & ASSOCIATES, INC. is the top corporate investor, holding 0 shares valued at -. A 0% stake in Corbus Pharmaceuticals Holdings, Inc. is owned by the company. ARIES WEALTH MANAGEMENT owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the CRBP insiders holding of 0.7% of the stake in company, CORMORANT ASSET MANAGEMENT, LP, 10 percent owner, holds the largest shares of 2.34M. WHITE BARBARA, Chief Medical Officer, is the second largest CRBP insider with ownership of 206.22K shares. COHEN YUVAL, Chief Executive Officer, stands third with possession of 174.32K shares of that stake.
| Insiders | Designation | Shares Held |
|---|
| CORMORANT ASSET MANAGEMENT, LP | 10 percent owner | 2.34M |
| WHITE BARBARA | Chief Medical Officer | 206.22K |
| COHEN YUVAL | Chief Executive Officer | 174.32K |
| MORAN SEAN F. | Chief Financial Officer | 96.69K |
| SMETHURST DOMINIC | Chief Medical Officer | 95.89K |
| HODGSON IAN | Chief Operating Officer | 51.08K |
| CATLIN AVERY W | director | 47K |
| DISCORDIA ROBERT PAUL | Chief Operating Officer | 35.49K |
| MILLIAN CRAIG STUART | Chief Operating Officer | 27K |
| HOLMER ALAN F | director | 22.5K |
| PANAYIOTOPOULOS PARIS | director | 14.29K |
| HOCHMAN DAVID P | director | 7K |
| ALTMEYER ANNE | director | 6.19K |
| JENKINS JOHN KENNETH | director | 33 |
